메뉴 건너뛰기




Volumn 12, Issue 8, 2009, Pages 837-840

Gene polymorphisms and chemotherapy in non-small cell lung cancer

Author keywords

Drug therapy; Genetic polymorphism; Lung neoplasms

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; CARBOPLATIN; CARBOXYLESTERASE; CISPLATIN; CYTOCHROME P450 3A4; DOCETAXEL; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; GEFITINIB; GEMCITABINE; GLUCURONOSYLTRANSFERASE 1A7; GLUCURONOSYLTRANSFERASE 1A9; IRINOTECAN; NAVELBINE; ORGANIC ANION TRANSPORTER 1; PACLITAXEL; TUMOR MARKER; XERODERMA PIGMENTOSUM GROUP A PROTEIN; XERODERMA PIGMENTOSUM GROUP D PROTEIN; XRCC1 PROTEIN; XRCC3 PROTEIN;

EID: 69949162040     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.1009-3419.2009.08.01     Document Type: Review
Times cited : (15)

References (36)
  • 1
    • 34547754569 scopus 로고    scopus 로고
    • NAT2 and CYP1A2 polymorphisms and lung cancer risk in relation to smoking status
    • Osawa Y, Osawa K, Miyaishi A, et al. NAT2 and CYP1A2 polymorphisms and lung cancer risk in relation to smoking status. Asian Pac J Cancer Prev, 2007, 8(1): 103-108.
    • (2007) Asian Pac J Cancer Prev , vol.8 , Issue.1 , pp. 103-108
    • Osawa, Y.1    Osawa, K.2    Miyaishi, A.3
  • 2
    • 0035895504 scopus 로고    scopus 로고
    • Human DNA repair genes
    • Wood RD, Mitchell M, Sgouros J, et al. Human DNA repair genes. Science, 2001, 291(5507): 1284-1289.
    • (2001) Science , vol.291 , Issue.5507 , pp. 1284-1289
    • Wood, R.D.1    Mitchell, M.2    Sgouros, J.3
  • 3
    • 62549137858 scopus 로고    scopus 로고
    • MUTYH Gln324His gene polymorphism and genetic susceptibility for lung cancer in a Japanese population
    • Miyaishi A, Osawa K, Osawa Y, et al. MUTYH Gln324His gene polymorphism and genetic susceptibility for lung cancer in a Japanese population. J Exp Clin Cancer Res, 2009, 28: 10.
    • (2009) J Exp Clin Cancer Res , vol.28 , pp. 10
    • Miyaishi, A.1    Osawa, K.2    Osawa, Y.3
  • 4
    • 33745186494 scopus 로고    scopus 로고
    • Pharmacogenetics approach to therapeutics
    • Koo SH, Lee EJ. Pharmacogenetics approach to therapeutics. Clin Exp Pharmacol Physiol, 2006, 33(5-6): 525-532.
    • (2006) Clin Exp Pharmacol Physiol , vol.33 , Issue.5-6 , pp. 525-532
    • Koo, S.H.1    Lee, E.J.2
  • 6
    • 45849135654 scopus 로고    scopus 로고
    • Impact of CYP3A4 haplotypes on irinotecan pharmacokinetics in Japanese cancer patients
    • Sai K, Saito Y, Fukushima-Uesaka H, et al. Impact of CYP3A4 haplotypes on irinotecan pharmacokinetics in Japanese cancer patients. Cancer Chemother Pharmacol, 2008, 62(3): 529-537.
    • (2008) Cancer Chemother Pharmacol , vol.62 , Issue.3 , pp. 529-537
    • Sai, K.1    Saito, Y.2    Fukushima-Uesaka, H.3
  • 7
    • 0034892379 scopus 로고    scopus 로고
    • Clinical pharmacokinetics and metabolism of irinotecan (CPT-11)
    • Mathijssen RH, van Alphen RJ, Verweij J, et al. Clinical pharmacokinetics and metabolism of irinotecan (CPT-11). Clin Cancer Res, 2001, 7(8): 2182-2194.
    • (2001) Clin Cancer Res , vol.7 , Issue.8 , pp. 2182-2194
    • Mathijssen, R.H.1    Van Alphen, R.J.2    Verweij, J.3
  • 10
    • 0032767352 scopus 로고    scopus 로고
    • UDP-glucuronosyltransferase (UGT1A1*28 and UGT1A6*2) polymorphisms in Caucasians and Asians: Relationships to serum bilirubin concentrations
    • Lampe JW, Bigler J, Horner NK, et al. UDP-glucuronosyltransferase (UGT1A1*28 and UGT1A6*2) polymorphisms in Caucasians and Asians: relationships to serum bilirubin concentrations. Pharmacogenetics, 1999, 9(3): 341-349. (Pubitemid 29376378)
    • (1999) Pharmacogenetics , vol.9 , Issue.3 , pp. 341-349
    • Lampe, J.W.1    Bigler, J.2    Horner, N.K.3    Potter, J.D.4
  • 12
    • 9144265660 scopus 로고    scopus 로고
    • Weekly regimen of irinotecan/docetaxel in previously treated non-small cell lung cancer patients and correlation with uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) polymorphism
    • Font A, Sánchez JM, Tarón M, et al Weekly regimen of irinotecan/docetaxel in previously treated non-small cell lung cancer patients and correlation with uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) polymorphism. Invest New Drugs, 2003, 21(4): 435-443.
    • (2003) Invest New Drugs , vol.21 , Issue.4 , pp. 435-443
    • Font, A.1    Sánchez, J.M.2    Tarón, M.3
  • 13
    • 34547788826 scopus 로고    scopus 로고
    • Role of UGT1A1*6, UGT1A1*28 and ABCG2 c.421C>A polymorphisms in irinotecan-induced neutropenia in Asian cancer patients
    • Jada SR, Lim R, Wong CI, et al. Role of UGT1A1*6, UGT1A1*28 and ABCG2 c.421C>A polymorphisms in irinotecan-induced neutropenia in Asian cancer patients. Cancer Sci, 2007, 98(9): 1461-1467.
    • (2007) Cancer Sci , vol.98 , Issue.9 , pp. 1461-1467
    • Jada, S.R.1    Lim, R.2    Wong, C.I.3
  • 14
    • 33744804311 scopus 로고    scopus 로고
    • Comprehensive analysis of UGT1A polymorphisms predictive for pharmacokinetics and treatment outcome in patients with non-small-cell lung cancer treated with irinotecan and cisplatin
    • Han JY, Lim HS, Shin ES, et al. Comprehensive analysis of UGT1A polymorphisms predictive for pharmacokinetics and treatment outcome in patients with non-small-cell lung cancer treated with irinotecan and cisplatin. J Clin Oncol, 2006, 24(15): 2237-2244.
    • (2006) J Clin Oncol , vol.24 , Issue.15 , pp. 2237-2244
    • Han, J.Y.1    Lim, H.S.2    Shin, E.S.3
  • 16
    • 37549028363 scopus 로고    scopus 로고
    • Influence of the organic anion-transporting polypeptide 1B1 (OATP1B1) polymorphisms on irinotecan-pharmacokinetics and clinical outcome of patients with advanced non-small cell lung cancer
    • Han JY, Lim HS, Shin ES, et al. Influence of the organic anion-transporting polypeptide 1B1 (OATP1B1) polymorphisms on irinotecan-pharmacokinetics and clinical outcome of patients with advanced non-small cell lung cancer. Lung Cancer, 2008, 59(1): 69-75.
    • (2008) Lung Cancer , vol.59 , Issue.1 , pp. 69-75
    • Han, J.Y.1    Lim, H.S.2    Shin, E.S.3
  • 18
    • 34250825286 scopus 로고    scopus 로고
    • Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan-pharmacokinetics and clinical outcome in patients with advanced non-small cell lung cancer
    • Han JY, Lim HS, Yoo YK, et al. Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan-pharmacokinetics and clinical outcome in patients with advanced non-small cell lung cancer. Cancer, 2007, 110(1): 138-147.
    • (2007) Cancer , vol.110 , Issue.1 , pp. 138-147
    • Han, J.Y.1    Lim, H.S.2    Yoo, Y.K.3
  • 19
    • 0029618266 scopus 로고
    • DNA repair in humans
    • Sancar A. DNA repair in humans. Annu Rev Genet, 1995, 29: 69-105.
    • (1995) Annu Rev Genet , vol.29 , pp. 69-105
    • Sancar, A.1
  • 20
    • 2342616723 scopus 로고    scopus 로고
    • Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy
    • DOI 10.1016/j.lungcan.2003.11.019, PII S0169500203006342
    • Ryu JS, Hong YC, Han HS, et al. Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy. Lung Cancer, 2004, 44(3): 311-316. (Pubitemid 38609439)
    • (2004) Lung Cancer , vol.44 , Issue.3 , pp. 311-316
    • Ryu, J.-S.1    Hong, Y.-C.2    Han, H.-S.3    Lee, J.-E.4    Kim, S.5    Park, Y.-M.6    Kim, Y.-C.7    Hwang, T.-S.8
  • 22
    • 4143051317 scopus 로고    scopus 로고
    • Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy
    • DOI 10.1158/1078-0432.CCR-04-0247
    • Zhou W, Gurubhagavatula S, Liu G, et al. Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy. Clin Cancer Res, 2004, 10(15): 4939-4943. (Pubitemid 39099767)
    • (2004) Clinical Cancer Research , vol.10 , Issue.15 , pp. 4939-4943
    • Zhou, W.1    Gurubhagavatula, S.2    Liu, G.3    Park, S.4    Neuberg, D.S.5    Wain, J.C.6    Lynch, T.J.7    Su, L.8    Christiani, D.C.9
  • 23
    • 33645298447 scopus 로고    scopus 로고
    • Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients
    • de las Peñas R, Sanchez-Ronco M, Alberola V, et al. Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients. Ann Oncol, 2006, 17(4): 668-675.
    • (2006) Ann Oncol , vol.17 , Issue.4 , pp. 668-675
    • De Las Peñas, R.1    Sanchez-Ronco, M.2    Alberola, V.3
  • 24
    • 41549095093 scopus 로고    scopus 로고
    • Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients
    • Tibaldi C, Giovannetti E, Vasile E, et al. Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients. Clin Cancer Res, 2008, 14(6): 1797-1803.
    • (2008) Clin Cancer Res , vol.14 , Issue.6 , pp. 1797-1803
    • Tibaldi, C.1    Giovannetti, E.2    Vasile, E.3
  • 26
    • 66449119340 scopus 로고    scopus 로고
    • XPA A23G polymorphism is associated with the elevated response to platinum-based chemotherapy in advanced non-small cell lung cancer
    • Shanghai
    • Feng J, Sun X, Sun N, et al. XPA A23G polymorphism is associated with the elevated response to platinum-based chemotherapy in advanced non-small cell lung cancer. Acta Biochim Biophys Sin (Shanghai), 2009, 41(5): 429-435.
    • (2009) Acta Biochim Biophys Sin , vol.41 , Issue.5 , pp. 429-435
    • Feng, J.1    Sun, X.2    Sun, N.3
  • 27
    • 34548161176 scopus 로고    scopus 로고
    • No association of ERCC1 C8092A and T19007C polymorphisms to cancer risk: A meta-analysis
    • DOI 10.1038/sj.ejhg.5201855, PII 5201855
    • Li Y, Gu S, Wu Q, et al. No association of ERCC1 C8092A and T19007C polymorphisms to cancer risk: a meta-analysis. Eur J Hum Genet, 2007, 15(9): 967-973. (Pubitemid 47308473)
    • (2007) European Journal of Human Genetics , vol.15 , Issue.9 , pp. 967-973
    • Li, Y.1    Gu, S.2    Wu, Q.3    Li, Y.4    Fu, X.5    Mao, Y.6    Huang, Y.7    Xie, Y.8
  • 31
    • 33847323129 scopus 로고    scopus 로고
    • Epidermal growth factor receptor mutations in lung cancer
    • DOI 10.1038/nrc2088, PII NRC2088
    • Sharma SV, Bell DW, Settleman J, et al. Epidermal growth factor receptor mutations in lung cancer. Nat Rev Cancer, 2007, 7(3): 169-181. (Pubitemid 46316032)
    • (2007) Nature Reviews Cancer , vol.7 , Issue.3 , pp. 169-181
    • Sharma, S.V.1    Bell, D.W.2    Settleman, J.3    Haber, D.A.4
  • 32
    • 58949098405 scopus 로고    scopus 로고
    • Epidermal growth factor receptor intron-1 polymorphism predicts gefitinib outcome in advanced non-small cell lung cancer
    • Tiseo M, Capelletti M, De Palma G, et al. Epidermal growth factor receptor intron-1 polymorphism predicts gefitinib outcome in advanced non-small cell lung cancer. J Thorac Oncol, 2008, 3(10): 1104-1111.
    • (2008) J Thorac Oncol , vol.3 , Issue.10 , pp. 1104-1111
    • Tiseo, M.1    Capelletti, M.2    De Palma, G.3
  • 33
    • 67349206986 scopus 로고    scopus 로고
    • EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment
    • Huang CL, Yang CH, Yeh KH, et al. EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment. Lung Cancer, 2009, 64(3): 346-351.
    • (2009) Lung Cancer , vol.64 , Issue.3 , pp. 346-351
    • Huang, C.L.1    Yang, C.H.2    Yeh, K.H.3
  • 34
    • 11244319884 scopus 로고    scopus 로고
    • A functional common polymorphism in a Sp1 recognition site of the epidermal growth factor receptor gene promoter
    • Liu W, Innocenti F, Wu MH, et al. A functional common polymorphism in a Sp1 recognition site of the epidermal growth factor receptor gene promoter. Cancer Res, 2005, 65(1): 46-53. (Pubitemid 40070794)
    • (2005) Cancer Research , vol.65 , Issue.1 , pp. 46-53
    • Liu, W.1    Innocenti, F.2    Wu, M.H.3    Desai, A.A.4    Dolan, M.E.5    Cook Jr., E.H.6    Ratain, M.J.7
  • 35
    • 40949096067 scopus 로고    scopus 로고
    • Epidermal growth factor receptor polymorphisms and clinical outcomes in non-small-cell lung cancer patients treated with gefitinib
    • Liu G, Gurubhagavatula S, Zhou W, et al. Epidermal growth factor receptor polymorphisms and clinical outcomes in non-small-cell lung cancer patients treated with gefitinib. Pharmacogenomics J, 2008, 8(2): 129-138.
    • (2008) Pharmacogenomics J , vol.8 , Issue.2 , pp. 129-138
    • Liu, G.1    Gurubhagavatula, S.2    Zhou, W.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.